Velimir A. Luketic

Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities

Arun J. Sanyal, Carol Campbell–Sargent, Faridoddin Mirshahi et al. · Gastroenterology · 2001 · 2.1K citations

Obesity, Metabolic Syndrome, Insulin Resistance +11

Clinical and Histologic Spectrum of Nonalcoholic Fatty Liver Disease Associated With Normal Alt Values

P MOFRAD, Melissa J. Contos, Mahmadul Haque et al. · Hepatology · 2003 · 1.2K citations · Full text

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

Frederik Nevens, Pietro Andreoné, G. Mazzella et al. · New England Journal of Medicine · 2016 · 1.1K citations · Full text

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Vlad Ratziu, Stephen A. Harrison, Sven Francque et al. · Gastroenterology · 2016 · 993 citations · Full text